| Targeted therapy with the T-cell–engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results … MS Topp, P Kufer, N Gökbuget, M Goebeler, M Klinger, S Neumann, ... Journal of clinical oncology 29 (18), 2493-2498, 2011 | 1041 | 2011 |
| The MLL recombinome of acute leukemias in 2017 C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ... Leukemia 32 (2), 273-284, 2018 | 671 | 2018 |
| The MLL recombinome of acute leukemias in 2013 C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ... Leukemia 27 (11), 2165-2176, 2013 | 563 | 2013 |
| Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL MS Topp, N Gökbuget, G Zugmaier, E Degenhard, ME Goebeler, ... Blood, The Journal of the American Society of Hematology 120 (26), 5185-5187, 2012 | 542 | 2012 |
| New insights to the MLL recombinome of acute leukemias C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ... Leukemia 23 (8), 1490-1499, 2009 | 516 | 2009 |
| Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial D Hoelzer, J Walewski, H Döhner, A Viardot, W Hiddemann, ... Blood, The Journal of the American Society of Hematology 124 (26), 3870-3879, 2014 | 303 | 2014 |
| The MLL recombinome of acute leukemias C Meyer, B Schneider, S Jakob, S Strehl, A Attarbaschi, S Schnittger, ... Leukemia 20 (5), 777-784, 2006 | 281 | 2006 |
| Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR–ABL1-positive acute lymphoblastic leukemia H Pfeifer, B Wassmann, W Bethge, J Dengler, M Bornhäuser, M Stadler, ... Leukemia 27 (6), 1254-1262, 2013 | 253 | 2013 |
| Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts O Blau, CD Baldus, WK Hofmann, G Thiel, F Nolte, T Burmeister, ... Blood, The Journal of the American Society of Hematology 118 (20), 5583-5592, 2011 | 214 | 2011 |
| Patients' age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group T Burmeister, S Schwartz, CR Bartram, N Gökbuget, D Hoelzer, E Thiel Blood, The Journal of the American Society of Hematology 112 (3), 918-919, 2008 | 171 | 2008 |
| Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations M Neumann, S Heesch, N Gökbuget, S Schwartz, C Schlee, O Benlasfer, ... Blood cancer journal 2 (1), e55-e55, 2012 | 145 | 2012 |
| High Expression of the ETS Transcription Factor ERG Predicts Adverse Outcome in Acute T-Lymphoblastic Leukemia in Adults CD Baldus, T Burmeister, P Martus, S Schwartz, N Gökbuget, ... Journal of clinical oncology 24 (29), 4714-4720, 2006 | 142 | 2006 |
| Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia M Kontro, H Kuusanmäki, S Eldfors, T Burmeister, EI Andersson, ... Leukemia 28 (8), 1738-1742, 2014 | 126 | 2014 |
| FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors M Neumann, E Coskun, L Fransecky, LH Mochmann, I Bartram, ... PloS one 8 (1), e53190, 2013 | 124 | 2013 |
| Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome CD Baldus, P Martus, T Burmeister, S Schwartz, N Gokbuget, ... Journal of clinical oncology 25 (24), 3739-3745, 2007 | 114 | 2007 |
| The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group T Burmeister, C Meyer, S Schwartz, J Hofmann, M Molkentin, E Kowarz, ... Blood, The Journal of the American Society of Hematology 113 (17), 4011-4015, 2009 | 110 | 2009 |
| Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia T Burmeister, N Gökbuget, S Schwartz, L Fischer, D Hubert, A Sindram, ... haematologica 95 (2), 241, 2010 | 104 | 2010 |
| BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features NR Neuendorff, T Burmeister, B Dörken, J Westermann Annals of Hematology 95, 1211-1221, 2016 | 103 | 2016 |
| Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10−/CD24−/CD65s+/CD15+ B-cell phenotype S Schwartz, H Rieder, B Schläger, T Burmeister, L Fischer, E Thiel Leukemia 17 (8), 1589-1595, 2003 | 103 | 2003 |
| Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes K Jahnke, M Hummel, A Korfel, T Burmeister, P Kiewe, HA Klasen, ... Journal of clinical oncology 24 (29), 4754-4757, 2006 | 99 | 2006 |
